BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND FGFR1, CEK, 2260, ENSG00000077782, P11362, FLT2, CD331, H3, HBGFR, FGFBR, H5, KAL2, H2, BFGFR, N-SAM, H4 AND Treatment
134 results:

  • 1. Comprehensive Analysis of Clinically Relevant Copy Number Alterations (CNAs) Using a 523-Gene Next-Generation Sequencing Panel and NxClinical Software in Solid Tumors.
    Gupta V; Vashisht V; Vashisht A; Mondal AK; Alptekin A; Singh H; Kolhe R
    Genes (Basel); 2024 Mar; 15(4):. PubMed ID: 38674331
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Circular RNA circTATDN3 promotes the Warburg effect and proliferation in colorectal cancer.
    Lin J; Zhong W; Lyu Z; Peng J; Rong Y; Zeng K; Lai J; Wu D; Wang J; Li Y; Zheng J; Zhang J; Pan Z
    Cancer Lett; 2024 May; 589():216825. PubMed ID: 38548218
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Establishment and characterization of two novel patient-derived cell lines from giant cell tumor of bone: NCC-GCTB8-C1 and NCC-GCTB9-C1.
    Adachi Y; Noguchi R; Yoshimatsu Y; Sin Y; Osaki J; Ono T; Iwata S; Akiyama T; Tsuchiya R; Toda Y; Ishihara S; Ogura K; Kobayashi E; Kojima N; Yoshida A; Yokoo H; Kawai A; Kondo T
    Hum Cell; 2024 May; 37(3):874-885. PubMed ID: 38466561
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Fibroblast growth factor receptor 1 inhibition suppresses pancreatic cancer chemoresistance and chemotherapy-driven aggressiveness.
    Lin Q; Serratore A; Niu J; Shen S; Roy Chaudhuri T; Ma WW; Qu J; Kandel ES; Straubinger RM
    Drug Resist Updat; 2024 Mar; 73():101064. PubMed ID: 38387284
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. An Fc-modified monoclonal antibody as novel treatment option for pancreatic cancer.
    Lutz MS; Wang K; Jung G; Salih HR; Hagelstein I
    Front Immunol; 2024; 15():1343929. PubMed ID: 38322253
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Altered histone acetylation patterns in pancreatic cancer cell lines induce subtype‑specific transcriptomic and phenotypical changes.
    Zhou Q; Pichlmeier S; Denz AM; Schreiner N; Straub T; Benitz S; Wolff J; Fahr L; Del Socorro Escobar Lopez M; Kleeff J; Mayerle J; Mahajan UM; Regel I
    Int J Oncol; 2024 Mar; 64(3):. PubMed ID: 38240084
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. DAXX promotes centromeric stability independently of ATRX by preventing the accumulation of R-loop-induced DNA double-stranded breaks.
    Pinto LM; Pailas A; Bondarchenko M; Sharma AB; Neumann K; Rizzo AJ; Jeanty C; Nicot N; Racca C; Graham MK; Naughton C; Liu Y; Chen CL; Meakin PJ; Gilbert N; Britton S; Meeker AK; Heaphy CM; Larminat F; Van Dyck E
    Nucleic Acids Res; 2024 Feb; 52(3):1136-1155. PubMed ID: 38038252
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. EBF2 Links KMT2D-Mediated H3K4me1 to Suppress pancreatic cancer Progression via Upregulating KLLN.
    Yao B; Xing M; Meng S; Li S; Zhou J; Zhang M; Yang C; Qu S; Jin Y; Yuan H; Zen K; Ma C
    Adv Sci (Weinh); 2024 Jan; 11(2):e2302037. PubMed ID: 38015024
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Expression of fibroblast growth factor receptor 1 correlates inversely with the efficacy of single-agent fibroblast growth factor receptor-specific inhibitors in pancreatic cancer.
    Lin Q; Serratore A; Perri J; Roy Chaudhuri T; Qu J; Ma WW; Kandel ES; Straubinger RM
    Br J Pharmacol; 2024 May; 181(9):1383-1403. PubMed ID: 37994108
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Preconditioning of radiotherapy enhances efficacy of B7-H3-CAR-T in treating solid tumor models.
    Wang T; Zhang K; You F; Ma R; Yang N; Tian S; An G; Yang L
    Life Sci; 2023 Oct; 331():122024. PubMed ID: 37574043
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Fibronectin fragments generated by pancreatic trypsin act as endogenous inhibitors of pancreatic tumor growth.
    Resovi A; Persichitti P; Brunelli L; Minoli L; Borsotti P; Garattini G; Tironi M; Dugnani E; Redegalli M; De Simone G; Pastorelli R; Bani MR; Piemonti L; Mosher DF; Giavazzi R; Taraboletti G; Belotti D
    J Exp Clin Cancer Res; 2023 Aug; 42(1):201. PubMed ID: 37559126
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Discovery of a pyrrole-pyridinimidazole derivative as novel SIRT6 inhibitor for sensitizing pancreatic cancer to gemcitabine.
    Song N; Guan X; Zhang S; Wang Y; Wang X; Lu Z; Chong D; Wang JY; Yu R; Yu W; Jiang T; Gu Y
    Cell Death Dis; 2023 Aug; 14(8):499. PubMed ID: 37542062
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. IgG-based B7-H3xCD3 bispecific antibody for treatment of pancreatic, hepatic and gastric cancer.
    Lutz MS; Zekri L; Weßling L; Berchtold S; Heitmann JS; Lauer UM; Jung G; Salih HR
    Front Immunol; 2023; 14():1163136. PubMed ID: 37122707
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. All you need to know about gastrinoma today | Gastrinoma and Zollinger-Ellison syndrome: A thorough update.
    Chatzipanagiotou O; Schizas D; Vailas M; Tsoli M; Sakarellos P; Sotiropoulou M; Papalambros A; Felekouras E
    J Neuroendocrinol; 2023 Apr; 35(4):e13267. PubMed ID: 37042078
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Chloroquine reduces neutrophil extracellular trap (NET) formation through inhibition of peptidyl arginine deiminase 4 (PAD4).
    Ivey AD; Matthew Fagan B; Murthy P; Lotze MT; Zeh HJ; Hazlehurst LA; Geldenhuys WJ; Boone BA
    Clin Exp Immunol; 2023 Mar; 211(3):239-247. PubMed ID: 36655514
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Nicotinamide N -methyltransferase promotes M2 macrophage polarization by IL6 and MDSC conversion by GM-CSF in gallbladder carcinoma.
    Li Y; Yang B; Miao H; Liu L; Wang Z; Jiang C; Yang Y; Qiu S; Li X; Geng Y; Zhang Y; Liu Y
    Hepatology; 2023 Nov; 78(5):1352-1367. PubMed ID: 36633260
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The histone deacetylase inhibitor M344 as a multifaceted therapy for pancreatic cancer.
    Knoche SM; Brumfield GL; Goetz BT; Sliker BH; Larson AC; Olson MT; Poelaert BJ; Bavari A; Yan Y; Black JD; Solheim JC
    PLoS One; 2022; 17(9):e0273518. PubMed ID: 36126055
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Novel protein kinase inhibitor TT-00420 inhibits gallbladder cancer by inhibiting JNK/JUN-mediated signaling pathway.
    Miao H; Geng Y; Li Y; Tang S; Feng F; Li W; Li Y; Liu L; Zhang R; Qiu S; Wu Y; Wang Z; Wang Z; Shao Z; Liu K; Zou L; Yang M; Zhao Y; Chen C; Li Z; Zhang D; Peng P; Qiang X; Wu F; He Y; Chen L; Xiang D; Jiang X; Li M; Liu Y; Liu Y
    Cell Oncol (Dordr); 2022 Aug; 45(4):689-708. PubMed ID: 35870050
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Hyperglycemia Enhances Immunosuppression and Aerobic Glycolysis of pancreatic cancer Through Upregulating Bmi1-UPF1-HK2 Pathway.
    Wu S; Zhang H; Gao C; Chen J; Li H; Meng Z; Bai J; Shen Q; Wu H; Yin T
    Cell Mol Gastroenterol Hepatol; 2022; 14(5):1146-1165. PubMed ID: 35863742
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Anti-Extra Domain B Splice Variant of Fibronectin Antibody-Drug Conjugate Eliminates Tumors with Enhanced Efficacy When Combined with Checkpoint Blockade.
    Hooper AT; Marquette K; Chang CB; Golas J; Jain S; Lam MH; Guffroy M; Leal M; Falahatpisheh H; Mathur D; Chen T; Kelleher K; Khandke K; Muszynska E; Loganzo F; Rosfjord E; Lucas J; Kan Z; Subramanyam C; O'Donnell C; Neri D; Gerber HP; May C; Sapra P
    Mol Cancer Ther; 2022 Sep; 21(9):1462-1472. PubMed ID: 35793468
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 7.